Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol

Contraception

Volumn 79, Issue 2, 2009, Pages 84-90

  Raghavan, Sheila ^a   Comendant, Rodica ^b   Digol, Irena ^b   Ungureanu, Sergiu ^b   Friptu, Valentin ^b   Bracken, Hillary ^a   Winikoff, Beverly ^a  

^a GYNUITY HEALTH PROJECTS   (United States)

^b STATE UNIVERSITY OF MEDICINE AND PHARMACY NICOLAE TESTEMITANU   (Moldova)

Author keywords

Medical abortion; Mifepristone; Misoprostol; Oral; Sublingual

Indexed keywords

MIFEPRISTONE; MISOPROSTOL; MTPILL; PARACETAMOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG CHOICE; DRUG EFFICACY; FEMALE; FEVER; GESTATIONAL AGE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ABORTION; MUSCLE CRAMP; NAUSEA; PATIENT SATISFACTION; PELVIS PAIN SYNDROME; RANDOMIZED CONTROLLED TRIAL; VOMITING; WEAKNESS;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; FEMALE; HUMANS; MIDDLE AGED; MIFEPRISTONE; MISOPROSTOL; PATIENT SATISFACTION; PREGNANCY; YOUNG ADULT;

EID: 58149242220     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.09.001     Document Type: Article

References (30)

1. Winikoff B., Sivin I., Coyaji K.J., et al. Safety, efficacy and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol 176 (1997) 431-437
2. Winikoff B., Ellertson C., Elul B., and Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Arch Fam Med 7 (1998) 360-366
3. Peyron R., Aubeny E., Targosz V., et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 328 (1993) 1509-1513
4. Elul B., Hajri S., Ngoc N.N., et al. Can women in less-developed countries use a simplified medical abortion regimen?. Lancet 357 (2001) 1402-1405
5. World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomized trial. BJOG 107 (2000) 524-530
6. Ngoc N.T., Winikoff B., Clark S., et al. Safety, efficacy and acceptability of mifepristone-misoprostol medical abortion in Vietnam. Int Fam Plan Perspect 25 (1999) 10-14
7. Blum J., Hajri S., Chellit H., Ben Mansour F., Gueddana N., and Winikoff B. The medical abortion experiences of married and unmarried women in Tunis, Tunisia. Contraception 69 (2004) 63-69
8. Akin A., Blum J., Ozalp S., et al. Results and lessons learned from a small medical abortion clinical study in Turkey. Contraception 70 (2004) 401-406
9. el-Refaey H., Dhamnasekar R., Abdalla M., et al. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 332 (1995) 983-987
10. Tang O.S., Xu J., Cheng L., Lee S.W., and Ho P.C. Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation. Hum Reprod 17 (2002) 1738-1740
11. Schaff E., Fielding S., Elsinger S.H., Stadalius L.S., and Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 61 (2000) 46-61
12. Singh K.C., Ummat S., Rajaram S., and Goel N. First trimester abortion with mifepristone and three doses of sublingual misoprostol: a pilot study. Aust N Z J Obstet Gynaecol 45 (2005) 495-498
13. Schaff E.A., Fielding S.L., Westhoff C., et al. Vaginal misoprostol administered 1,2, or 3 days after mifepristone for early medical abortion: a randomized trial. JAMA 284 (2000) 1948-1953
14. Middleton T., Schaff E., Fielding S.L., et al. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Contraception 72 (2005) 328-332
15. von Hertzen H., Honkanen H., Piaggio G., et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. BJOG 110 (2003) 808-818
16. Creinin M.D., Schreiber C.A., Bednarek P., et al. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol 109 (2007) 885-894
17. Schaff E.A., Fielding S.L., and Westhoff C. Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mcg for abortion up to 63 days of pregnancy. Contraception 66 (2002) 247-250
18. Ngoc N.N., Nhan V.Q., Blum J., et al. Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam. BJOG 111 (2004) 814-819
19. Schaff E.A., Fielding S.L., and Westhoff C. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception 64 (2001) 81-85
20. Spitz I.M., Bardin C.W., Benton L., and Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 338 (1998) 1241-1247
21. Clark W., Shannon C., and Winikoff B. Misoprostol for uterine evacuation in induced abortion and pregnancy failure. Expert Rev Obstet Gynecol 2 (2007) 67-108
22. Ashok P.W., Penney G.C., Flett G.M.M., and Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 13 (1998) 2962-2965
23. Ho P.C., Ngai S.W., Liu K.L., Wong G.C.Y., and Lee S.W.H. Vaginal misoprostol compared with oral misoprostol in termination of second trimester pregnancy. Obstet Gynaecol 90 (1997) 735-738
24. Hamoda H., Ashok P.W., Flett G.M., and Templeton A. A randomized controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. BJOG 112 (2005) 1102-1108
25. Tang O.S., Schweer H., Seyberth H.W., Lee S.W., and Ho P.C. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 10 (2002) 332-336
26. Tang O.S., Chan C.C., Ng E.H., Lee S.W., and Ho P.C. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Hum Reprod 18 (2003) 2315-2318
27. Hamoda H., Ashok P.W., Dow J., Flett G.M., and Templeton A. A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation. Contraception 68 (2003) 335-338
28. Mundle S., Elul B., Anand A., Kalyanwala S., and Ughade S. Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center. Contraception 76 (2007) 66-70
29. Coyaji K., Elul B., Krishna U., et al. Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India. Contraception 66 (2002) 33-40
30. Jain J.K., Dutton C., Harwood B., Meckstroth K.R., and Mishell Jr. D.R. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Hum Reprod 17 (2002) 1477-1482